This article is distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
European Association for the Study of the Liver, European Organisation for Research and Treatement of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 2012; 56: 908-43. 10.1016/j.jhep.2011.12.001European Association for the Study of the Liver, European Organisation for Research and Treatement of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinomaJ Hepatol2012569084310.1016/j.jhep.2011.12.00122424438Open DOISearch in Google Scholar
Lammer J, Malagari K, Vogl T, Pilleul F, Denys A, Watkinson A, et al. Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study. Cardiovasc Intervent Radiol 2010; 33: 41–52. 10.1007/s00270-009-9711-719908093LammerJMalagariKVoglTPilleulFDenysAWatkinsonAProspective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V studyCardiovasc Intervent Radiol201033415210.1007/s00270-009-9711-7281679419908093Open DOISearch in Google Scholar
Dhanasekaran R, Kooby DA, Staley CA, Kauh JS, Khanna V, Kim HS, et al. Comparison of conventional transarterial chemoembolization (TACE) and chemoembolization with doxorubicin drug eluting beads (DEB) for unresectable hepatocelluar carcinoma (HCC). J Surg Oncol 2010; 101: 476-80. 10.1002/jso.2152220213741DhanasekaranRKoobyDAStaleyCAKauhJSKhannaVKimHSComparison of conventional transarterial chemoembolization (TACE) and chemoembolization with doxorubicin drug eluting beads (DEB) for unresectable hepatocelluar carcinoma (HCC)J Surg Oncol20101014768010.1002/jso.2152220213741Open DOISearch in Google Scholar
Malagari K, Pomoni M, Moschouris H, Bouma E, Koskinas J, Stefaniotou A, et al. Chemoembolization with doxorubicin-eluting beads for unresectable hepatocellular carcinoma: five-year survival analysis. Cardiovasc Intervent Radiol 2012; 35: 1119-28.10.1007/s00270-012-0394-022614031MalagariKPomoniMMoschourisHBoumaEKoskinasJStefaniotouAChemoembolization with doxorubicin-eluting beads for unresectable hepatocellular carcinoma: five-year survival analysisCardiovasc Intervent Radiol20123511192822614031Open DOISearch in Google Scholar
Varela M, Real MI, Burrel M, Forner A, Sala M, Brunet M, et al. Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics. J Hepatol 2007; 46: 474-81.1723948010.1016/j.jhep.2006.10.020VarelaMRealMIBurrelMFornerASalaMBrunetMChemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokineticsJ Hepatol2007464748117239480Search in Google Scholar
Popovic P, Stabuc B, Jansa R, Garbajs M. Survival of patients with intermediate stage hepatocellular carcinoma treated with superselective transarterial chemoembolization using doxorubicin-loaded DC Bead under conebeam computed tomography control. Radiol Oncol 2016; 50: 418-26. 10.1515/raon-2015-0045PopovicPStabucBJansaRGarbajsM.Survival of patients with intermediate stage hepatocellular carcinoma treated with superselective transarterial chemoembolization using doxorubicin-loaded DC Bead under conebeam computed tomography controlRadiol Oncol2016504182610.1515/raon-2015-0045512057427904450Open DOISearch in Google Scholar
Kettenbach J, Stadler A, Katzler IV, Schernthaner R, Blum M, Lammer J, et al. Drug-loaded microspheres for the treatment of liver cancer: review of current results. Cardiovasc Intervent Radiol 2008; 31: 468-76. 10.1007/s00270-007-9280-618228095KettenbachJStadlerAKatzlerIVSchernthanerRBlumMLammerJDrug-loaded microspheres for the treatment of liver cancer: review of current resultsCardiovasc Intervent Radiol2008314687610.1007/s00270-007-9280-618228095Open DOISearch in Google Scholar
Malgari K, Chatzimichael K, Alexopöulou E, Kelekis A, Hall B, Dourakis S, et al. Transarterial chemoembolisation of unresectable hepatocelular carcinoma with drug eluting beads: results of an open-label study of 62 patients. Cardiovasc Interv Radiol 2008; 31: 269-80.10.1007/s00270-007-9226-zMalgariKChatzimichaelKAlexopöulouEKelekisAHallBDourakisSTransarterial chemoembolisation of unresectable hepatocelular carcinoma with drug eluting beads: results of an open-label study of 62 patientsCardiovasc Interv Radiol2008312698017999110Open DOISearch in Google Scholar
Lencioni R, Llovet JM. Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Sem Liver Disease 2010; 30: 52-60. 10.1055/s-0030-1247132LencioniRLlovetJM.Modified RECIST (mRECIST) assessment for hepatocellular carcinomaSem Liver Disease201030526010.1055/s-0030-124713220175033Open DOISearch in Google Scholar
Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival. Hepatology 2003; 37: 429-42.1254079410.1053/jhep.2003.50047LlovetJMBruixJ.Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survivalHepatology2003374294212540794Search in Google Scholar
Takayasu K, Arii S, Ikai I, Omata M, Okita K, Ichida T, et al. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients. Gastroenterology 2006; 131: 461-9.1689060010.1053/j.gastro.2006.05.021TakayasuKAriiSIkaiIOmataMOkitaKIchidaTProspective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patientsGastroenterology2006131461916890600Search in Google Scholar
Burrel M, Reig M, Forner A, Barrufet M, de Lope CR, Tremosini S, et al. Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using Drug Eluting Beads. Implications for clinical practice and trial design. J Hepatol 2012; 56: 1330-5. 10.1016/j.jhep.2012.01.00822314428BurrelMReigMFornerABarrufetMde LopeCRTremosiniSSurvival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using Drug Eluting Beads. Implications for clinical practice and trial designJ Hepatol2012561330510.1016/j.jhep.2012.01.00822314428Open DOISearch in Google Scholar
Fatourou EM, Tsochatzis EA. ART and science in using transarterial chemoembolization for retreating patients with hepatocellular carcinoma. Hepatobiliary Surg Nutr 2014; 3: 415-8. 10.3978/j.issn.2304-3881.2014.07.0125568865FatourouEMTsochatzisEA.ART and science in using transarterial chemoembolization for retreating patients with hepatocellular carcinomaHepatobiliary Surg Nutr20143415810.3978/j.issn.2304-3881.2014.07.01427311425568865Open DOISearch in Google Scholar
Tsochatzis EA, Fatourou E, O’Beirne J, Meyer T, Burroughs AK. Transarterial chemoembolization and bland embolization for hepatocellular carcinoma. World J Gastroenterol 2014; 20: 3069-77. 10.3748/wjg.v20.i12.306924695579TsochatzisEAFatourouEO’BeirneJMeyerTBurroughsAK.Transarterial chemoembolization and bland embolization for hepatocellular carcinomaWorld J Gastroenterol20142030697710.3748/wjg.v20.i12.3069396437924695579Open DOISearch in Google Scholar
Yang HF, Du Y, Ni JX, Zhou XP, Li JD, Zhang Q, et al. Perfusion computed tomography evaluation of angiogenesis in liver cancer. Eur Radiol 2010; 20: 1424-30. 10.1007/s00330-009-1693-y20179942YangHFDuYNiJXZhouXPLiJDZhangQPerfusion computed tomography evaluation of angiogenesis in liver cancerEur Radiol20102014243010.1007/s00330-009-1693-y20179942Open DOISearch in Google Scholar
Morsbach F, Pfammatter T, Reiner CS, Fischer MA, Sah BR, Winklhofer S, et al. Computed tomographic perfusion imaging for the prediction of response and survival to transarterial radioembolization of liver metastases. Invest Radiol 2013; 48: 787-94. 10.1097/RLI.0b013e31829810f723748229MorsbachFPfammatterTReinerCSFischerMASahBRWinklhoferSComputed tomographic perfusion imaging for the prediction of response and survival to transarterial radioembolization of liver metastasesInvest Radiol2013487879410.1097/RLI.0b013e31829810f723748229Open DOISearch in Google Scholar
Blomley MJ, Coulden R, Dawson P, Kormano M, Donlan P, Bufkin C, et al. Liver perfusion studied with ultrafast CT. J Comput Assist Tomogr 1995; 19: 424-33.779055310.1097/00004728-199505000-00016BlomleyMJCouldenRDawsonPKormanoMDonlanPBufkinCLiver perfusion studied with ultrafast CTJ Comput Assist Tomogr199519424337790553Search in Google Scholar
Garcia-Figueiras R, Goh VJ, Padhani AR, Baleato-González S, Garrido M, León L, et al. Ct perfusion in oncologic imaging: A useful tool? AJR Am J Roentgenol 2013; 200: 8-19. 10.2214/AJR.11.847623255736Garcia-FigueirasRGohVJPadhaniARBaleato-GonzálezSGarridoMLeónLCt perfusion in oncologic imaging: A useful tool?AJR Am J Roentgenol201320081910.2214/AJR.11.847623255736Open DOISearch in Google Scholar
Avsenik J, Bisdas S, Popovic KS. Blood-brain barrier permeability imaging using perfusion computed tomography. Radiol Oncol 2015; 49: 107-14. 10.2478/raon-2014-002926029020AvsenikJBisdasSPopovicKS.Blood-brain barrier permeability imaging using perfusion computed tomographyRadiol Oncol2015491071410.2478/raon-2014-0029438798526029020Open DOISearch in Google Scholar
Tsushima Y, Funabasama S, Aoki J, Sanada S, Endo K. Quantitative perfusion map of malignant liver tumors, created from dynamic computed tomography data. Acad Radiol 2004; 11: 215-23.1497459710.1016/S1076-6332(03)00578-6TsushimaYFunabasamaSAokiJSanadaSEndoK.Quantitative perfusion map of malignant liver tumors, created from dynamic computed tomography dataAcad Radiol20041121523Search in Google Scholar
Yang L, Zhang XM, Tan BX, Liu M, Dong GL, Zhai ZH. Computed tomographic perfusion imaging for the therapeutic response of chemoembolization for hepatocellular carcinoma. J Comput Assist Tomogr 2012; 36: 226-30. 10.1097/RCT.0b013e318245c23c22446364YangLZhangXMTanBXLiuMDongGLZhaiZH.Computed tomographic perfusion imaging for the therapeutic response of chemoembolization for hepatocellular carcinomaJ Comput Assist Tomogr2012362263010.1097/RCT.0b013e318245c23c22446364Open DOISearch in Google Scholar
Chen G, Ma DQ, He W, Zhang BF, Zhao LQ. Computed tomography perfusion in evaluating the therapeutic effect of transarterial chemoembolization for hepatocellular carcinoma. World J Gastroenterol 2008; 14: 5738-43.10.3748/wjg.14.573818837093ChenGMaDQHeWZhangBFZhaoLQ.Computed tomography perfusion in evaluating the therapeutic effect of transarterial chemoembolization for hepatocellular carcinomaWorld J Gastroenterol200814573843274821118837093Open DOISearch in Google Scholar
Sahani D, Holalkere DS, Mueller PR, Zhu AX. Advanced hepatocellular carcinoma: CT perfusion of liver and tumor tissue-initial experience. Radiology 2007; 243: 736-43.10.1148/radiol.243305202017517931SahaniDHolalkereDSMuellerPRZhuAX.Advanced hepatocellular carcinoma: CT perfusion of liver and tumor tissue-initial experienceRadiology20072437364317517931Open DOISearch in Google Scholar
Zhou ZF, Huang HL, Xu B, et al. Clinic application with MSCT perfusion in liver tumor. Linchuang Fangshexue Zazhi 2006; 25: 233-7.ZhouZFHuangHLXuBClinic application with MSCT perfusion in liver tumorLinchuang Fangshexue Zazhi2006252337Search in Google Scholar
Komemushi A, Tanigawa N, Kojima H, Kariya S, Sawada S. CT perfusion of the liver during selective hepatic arteriography: pure arterial blood perfusion of liver tumor and parenchyma. Radiat Med 2003; 21: 246-51.14743897KomemushiATanigawaNKojimaHKariyaSSawadaS.CT perfusion of the liver during selective hepatic arteriography: pure arterial blood perfusion of liver tumor and parenchymaRadiat Med20032124651Search in Google Scholar
Ebos JM, Kerbel RS. Antiangiogenic therapy: impact on invasion, disease progression, and metastasis. Nat Rev Clin Oncol 2011; 8: 210-21. 10.1038/nrclinonc.2011.2121364524EbosJMKerbelRS.Antiangiogenic therapy: impact on invasion, disease progression, and metastasisNat Rev Clin Oncol201182102110.1038/nrclinonc.2011.21454033621364524Open DOISearch in Google Scholar
De Robertis R, Tinazzi Martini P, Demozzi E, Puntel G, Ortolani S, Cingarlini S, et al. Prognostication and response assessment in liver and pancreatic tumors: the new imaging. World J Gastroenterol 2015; 21: 6794-808. 10.3748/wjg.v21.i22.679426078555De RobertisRTinazzi MartiniPDemozziEPuntelGOrtolaniSCingarliniSPrognostication and response assessment in liver and pancreatic tumors: the new imagingWorld J Gastroenterol201521679480810.3748/wjg.v21.i22.6794446271926078555Open DOISearch in Google Scholar
Ash L, Teknos TN, Gandhi D, Patel S, Mukherji SK. Head and neck squamous cell carcinoma: CT perfusion can help noninvasively predict intratumoral microvessel density. Radiology 2009; 251: 422-8. 10.1148/radiol.251208074319276321AshLTeknosTNGandhiDPatelSMukherjiSK.Head and neck squamous cell carcinoma: CT perfusion can help noninvasively predict intratumoral microvessel densityRadiology2009251422810.1148/radiol.251208074319276321Open DOISearch in Google Scholar
Chen Y, Zhang J, Dai J, Feng X, Lu H, Zhou C. Angiogenesis of renal cell carcinoma: perfusion CT findings. Abdom Imaging 2010; 35: 622-8. 10.1007/s00261-009-9565-019763683ChenYZhangJDaiJFengXLuHZhouC.Angiogenesis of renal cell carcinoma: perfusion CT findingsAbdom Imaging201035622810.1007/s00261-009-9565-019763683Open DOISearch in Google Scholar
D’Assignies G, Couvelard A, Bahrami S, Vullierme MP, Hammel P, Hentic O, et al. Pancreatic endocrine tumors: tumor blood flow assessed with perfusion CT reflects angiogenesis and correlates with prognostic factors. Radiology 2009; 250: 407-16. 10.1148/radiol.250108029119095784D’AssigniesGCouvelardABahramiSVulliermeMPHammelPHenticOPancreatic endocrine tumors: tumor blood flow assessed with perfusion CT reflects angiogenesis and correlates with prognostic factorsRadiology20092504071610.1148/radiol.250108029119095784Open DOISearch in Google Scholar
Fournier LS, Oudard S, Thiam R, Trinquart L, Banu E, Medioni J, et al. Metastatic renal carcinoma: evaluation of anti-angiogenic therapy with dynamic contrast enhanced CT. Radiology 2010; 256: 511-8. 10.1148/radiol.10091362FournierLSOudardSThiamRTrinquartLBanuEMedioniJMetastatic renal carcinoma: evaluation of anti-angiogenic therapy with dynamic contrast enhanced CTRadiology2010256511810.1148/radiol.1009136220551183Open DOISearch in Google Scholar
Bellomi M, Petralia G, Sonzogni A, Zampino MG, Rocca A. CT perfusion for the monitoring of neo-adjuvant chemoradiation therapy in rectal carcinoma. Radiology 2007; 244: 486-93.10.1148/radiol.2442061189BellomiMPetraliaGSonzogniAZampinoMGRoccaA.CT perfusion for the monitoring of neo-adjuvant chemoradiation therapy in rectal carcinomaRadiology20072444869317641369Open DOISearch in Google Scholar
Han KS, Jung DC, Choi HJ, Jeong MS, Cho KS, Joung JY, et al. Pretreatment assesment of tumor enhancement on contrast-enhanced computed tomography as a potential predictor of treatment outcome in metastatic renal cell carcinoma patients receiving antiangiogenic therapy. Cancer 2010; 116: 2332-42. 10.1002/cncr.25019HanKSJungDCChoiHJJeongMSChoKSJoungJYPretreatment assesment of tumor enhancement on contrast-enhanced computed tomography as a potential predictor of treatment outcome in metastatic renal cell carcinoma patients receiving antiangiogenic therapyCancer201011623324210.1002/cncr.2501920225226Open DOISearch in Google Scholar
Bisdas S, Surlan-Popovic K, Didanovic V, Vogl TJ. Functional CT of squamous cell carcinoma in the head and neck: repeatability of tumor and muscle quantitative measurements, inter- and intra-observer agreement. Eur Radiol 2008; 18: 2241-5. 10.1007/s00330-008-0990-118446342BisdasSSurlan-PopovicKDidanovicVVoglTJ.Functional CT of squamous cell carcinoma in the head and neck: repeatability of tumor and muscle quantitative measurements, inter- and intra-observer agreementEur Radiol2008182241510.1007/s00330-008-0990-118446342Open DOISearch in Google Scholar
Gandhi D, Chepeha DB, Miller T, Carlos RC, Bradford CR, Karamchandani R, et al. Correlation between initial and early follow-up CT perfusion parameters with endoscopic tumor response in patients with advanced squamous cell carcinomas of the oropharynx treated with organ-preservation therapy. AJNR Am J Neuroradiol 2006; 27: 101–6.16418366GandhiDChepehaDBMillerTCarlosRCBradfordCRKaramchandaniRCorrelation between initial and early follow-up CT perfusion parameters with endoscopic tumor response in patients with advanced squamous cell carcinomas of the oropharynx treated with organ-preservation therapyAJNR Am J Neuroradiol2006271016Search in Google Scholar
Surlan-Popovic K, Bisdas S, Rumboldt Z, Koh TS, Strojan P. Changes in perfusion CT of advanced squamous cell carcinoma of the head and neck treated during the course of concomitant chemoradiotherapy. AJNR Am J Neuroradiol 2010; 31: 570-5. 10.3174/ajnr.A185919875475Surlan-PopovicKBisdasSRumboldtZKohTSStrojanP.Changes in perfusion CT of advanced squamous cell carcinoma of the head and neck treated during the course of concomitant chemoradiotherapyAJNR Am J Neuroradiol201031570510.3174/ajnr.A1859796399419875475Open DOISearch in Google Scholar
Wang J, Wu N, Cham MD, Song Y. Tumor response in patients with advanced non-small cell lung cancer: perfusion CT evaluation of chemotherapy and radiation therapy. AJR 2009; 193: 1090-6. 10.2214/AJR.08.1367WangJWuNChamMDSongY.Tumor response in patients with advanced non-small cell lung cancer: perfusion CT evaluation of chemotherapy and radiation therapyAJR20091931090610.2214/AJR.08.136719770333Open DOISearch in Google Scholar
Jiang T, Kambadakone A, Kulkarni NM, Zhu AX, Sahani DV. Monitoring response to antiangiogenic treatment and predicting outcomes in advanced hepatocellular carcinoma using image biomarkers, CT perfusion, tumor density, and tumor size (RECIST). Invest Radiol 2012; 47: 11-7. 10.1097/RLI.0b013e3182199bb521512396JiangTKambadakoneAKulkarniNMZhuAXSahaniDV.Monitoring response to antiangiogenic treatment and predicting outcomes in advanced hepatocellular carcinoma using image biomarkers, CT perfusion, tumor density, and tumor size (RECIST)Invest Radiol20124711710.1097/RLI.0b013e3182199bb521512396Open DOISearch in Google Scholar
Petralia G, Fazio N, Bonello L, D’Andrea G, Radice D, Bellomi M. Perfusion computed tomography in patients with hepatocellular carcinoma treated with thalidomide: initial experience. J Comput Assist Tomogr 2011; 35: 195–201. 10.1097/RCT.0b013e31820ccf5121412089PetraliaGFazioNBonelloLD’AndreaGRadiceDBellomiM.Perfusion computed tomography in patients with hepatocellular carcinoma treated with thalidomide: initial experienceJ Comput Assist Tomogr20113519520110.1097/RCT.0b013e31820ccf5121412089Open DOISearch in Google Scholar
Michielsen K, De Keyzer F, Verslype C, Dymarkowski S, van Malenstein H, Oyen R, et al. Pretreatment DCE-MRI for prediction of PFS in patients with inoperable HCC treated with TACE. Cancer Imaging 2011; 11: 114.10.1102/1470-7330.2011.9058MichielsenKDe KeyzerFVerslypeCDymarkowskiSvan MalensteinHOyenRPretreatment DCE-MRI for prediction of PFS in patients with inoperable HCC treated with TACECancer Imaging201111114Open DOISearch in Google Scholar
Visualization of multistep hepatocarcinogenesis using various imaging biomarkers [internet]. ECR 2014. C-0120. Retrieved from: http://posterng.netkey.at/esr/viewing/index.php?module=viewing_poster&task=viewsection&pi=119549&ti=394293&searchkey=Visualization of multistep hepatocarcinogenesis using various imaging biomarkers [internet]ECR 2014. C-0120Retrieved fromhttp://posterng.netkey.at/esr/viewing/index.php?module=viewing_poster&task=viewsection&pi=119549&ti=394293&searchkey=Search in Google Scholar
Ippolito D, Capraro C, Casiraghi A, Cestari C, Sironi S. Quantitative assessment of tumour associated neovascularisation in patients with liver cirrhosis and hepatocellular carcinoma: role of dynamic-CT perfusion imaging. Eur Radiol 2012; 22: 803-11. 10.1007/s00330-011-2307-z22086560IppolitoDCapraroCCasiraghiACestariCSironiS.Quantitative assessment of tumour associated neovascularisation in patients with liver cirrhosis and hepatocellular carcinoma: role of dynamic-CT perfusion imagingEur Radiol2012228031110.1007/s00330-011-2307-z22086560Open DOISearch in Google Scholar
Sahani DV, Holalkere NS, Mueller PR, Zhu AX. Advanced hepatocellular carcinoma: CT perfusion of liver and tumor tissue--initial experience. Radiology 2007; 243: 736-43.10.1148/radiol.243305202017517931SahaniDVHolalkereNSMuellerPRZhuAX.Advanced hepatocellular carcinoma: CT perfusion of liver and tumor tissue--initial experienceRadiology20072437364317517931Open DOISearch in Google Scholar
Frampas E, Lassau N, Zappa M, Vullierme MP, Koscielny S, Vilgrain V. Advanced hepatocellular carcinoma: early evaluation of response to targeted therapy and prognostic value of perfusion CT and dynamic contrast enhanced-ultrasound. Preliminary results. Eur J Radiol 2013; 82: 205-11. 10.1016/j.ejrad.2012.12.004FrampasELassauNZappaMVulliermeMPKoscielnySVilgrainV.Advanced hepatocellular carcinoma: early evaluation of response to targeted therapy and prognostic value of perfusion CT and dynamic contrast enhanced-ultrasound. Preliminary resultsEur J Radiol2013822051110.1016/j.ejrad.2012.12.00423273822Open DOISearch in Google Scholar
Schmitz S, Rommel D, Michoux N, Lhommel R, Hanin FX, Duprez T, et al. Dynamic contrast-enhanced computed tomography to assess early activity of cetuximab in squamous cell carcinoma of the head and neck. Radiol Oncol 2015; 49: 17-25. 10.2478/raon-2014-003025810697SchmitzSRommelDMichouxNLhommelRHaninFXDuprezTDynamic contrast-enhanced computed tomography to assess early activity of cetuximab in squamous cell carcinoma of the head and neckRadiol Oncol201549172510.2478/raon-2014-0030436260225810697Open DOISearch in Google Scholar
Kim SH, Kamaya A, Willmann JK. CT perfusion of the liver: principles and applications in oncology. Radiology 2014; 272: 322-44. 10.1148/radiol.1413009125058132KimSHKamayaAWillmannJK.CT perfusion of the liver: principles and applications in oncologyRadiology20142723224410.1148/radiol.14130091426362625058132Open DOISearch in Google Scholar
Mazzei MA, Preda L, Cianfoni A, Volterrani L. CT Perfusion: Technical developments and current and future applications. Biomed Res Int 2015; 2015: 397521. 10.1155/2015/39752125695071MazzeiMAPredaLCianfoniAVolterraniL.CT Perfusion: Technical developments and current and future applicationsBiomed Res Int2015201539752110.1155/2015/397521432481025695071Open DOISearch in Google Scholar
